000			02122 a2200601 4500
005			20250513183206.0
264		0	_c19990615
008			199906s 0 0 eng d
022			_a0022-3565
040			_aNLM _beng _cNLM
100	1		_aWeiser, T
245	0	0	_aBIIR 561 CL: a novel combined antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and voltage-dependent sodium channels with anticonvulsive and neuroprotective properties. _h[electronic resource]
260			_bThe Journal of pharmacology and experimental therapeutics _cJun 1999
300			_a1343-9 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAnti-Anxiety Agents _xpharmacology
650	0	4	_aAnticonvulsants _xpharmacology
650	0	4	_aBatrachotoxins _xpharmacokinetics
650	0	4	_aBenzodiazepines
650	0	4	_aCell Membrane _xphysiology
650	0	4	_aCells, Cultured
650	0	4	_aCerebral Cortex _xcytology
650	0	4	_aElectroshock
650	0	4	_aEmbryo, Mammalian
650	0	4	_aGlutamic Acid _xmetabolism
650	0	4	_aIn Vitro Techniques
650	0	4	_aIschemic Attack, Transient _xphysiopathology
650	0	4	_aMale
650	0	4	_aMexiletine _xpharmacology
650	0	4	_aMice
650	0	4	_aNeurons _xcytology
650	0	4	_aNeuroprotective Agents _xpharmacology
650	0	4	_aOxadiazoles _xpharmacology
650	0	4	_aPatch-Clamp Techniques
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReceptors, AMPA _xantagonists & inhibitors
650	0	4	_aSodium Channel Blockers
650	0	4	_aSodium Channels _xphysiology
650	0	4	_aSynaptosomes _xdrug effects
650	0	4	_aVeratridine _xpharmacology
650	0	4	_aalpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid _xpharmacology
700	1		_aBrenner, M
700	1		_aPalluk, R
700	1		_aBechtel, W D
700	1		_aCeci, A
700	1		_aBrambilla, A
700	1		_aEnsinger, H A
700	1		_aSagrada, A
700	1		_aWienrich, M
773	0		_tThe Journal of pharmacology and experimental therapeutics _gvol. 289 _gno. 3 _gp. 1343-9
999			_c10295333 _d10295333